EC
CC icon

EntryPoint Capital’s Chemours CC Stock Holding History

EntryPoint Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,884
Closed -$424K – 750
2024
Q3 		$424K Buy
20,884
+9,428
+82% +$193K 0.24% 105
2024
Q2 		$259K Buy
11,456
+10,540
+1,151% +$276K 0.12% 260
2024
Q1 		$24.1K Buy
916
+545
+147% +$15.5K 0.02% 1036
2023
Q4 		$11.7K Buy
+371
New +$10.1K 0.01% 1137

Other funds holding CC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AWAM
Appian Way Asset Management New York $558M AUM 1.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EntryPoint Capital's CC Position: Q4 2024 in Review

EntryPoint Capital sold out of Chemours (CC) in Q4 2024, closing a stake of 20,884 shares — an estimated $424K sold.

EntryPoint Capital first reported a position in CC in Q4 2023 and held it in 4 quarters. The position peaked at $424K in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • EntryPoint Capital reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • EntryPoint Capital sold 20,884 Chemours shares in Q4 2024, an estimated $424K.
  • EntryPoint Capital first reported a position in Chemours in Q4 2023 and held it in 4 quarters.
  • EntryPoint Capital's Chemours position peaked at $424K in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.